Please enable JS

DISCOVER

INVESTIGATOR SITE MANAGEMENT

Clinical Trials Mobile Application

We provide innovative digital solutions aiming at facilitating patient recruitment in clinical studies, using current patients’ conditions and powerful build-in algorithms.

Get a demo

Our mission

SOME NUMBERS

Figure: Total R&D/clinical trials pipeline size, by year 2000-2022

They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor.
CT-SCOUT and ToTem4me facilitate the match between the patients and the studies.

50%

OF STUDIES FAIL TO MEET PATIENT RECRUITMENT DEADLINES

However, millions of patients visit clinical sites every day.
CT-SCOUT help investigators identify the ones that could benefit from a clinical study.

80%

OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY

Patients have become actors of their treatment conditions.
ToTem4me help them identify potential opportunities through clinical studies.

0.02%

OF THE PATIENTS ARE BEING OFFERED TO PARTICIPATE TO A CLINICAL STUDY

But 80% of patients would accept to participate t a clinical study.
CT-SCOUT contributes to increase the percentage of patients considered for clinical research.

2

WEEKS SET-UP TIME

No more than 2 weeks are required to get CT-SCOUT
or ToTem4me deployed for a clinical study

Our Solutions

We have customised digital solutions for the different contributors to the clinical research efforts.

corner top

CT-SCOUT

The missing link between sponsor & sites

A multi-device application based on a unique algorithmic model to enable all physicians to quickly detect in real-time, the clinical studies running at their sites, for which a patient is potentially eligible according to his/her current health conditions.

Find out more corner bottom
corner top

ToTem4me

The web application for patients

A multi-device application based on a unique algorithmic model, to enable patients, with the direct support of an expert-coordinator, to quickly detect the clinical studies running in their neighborhood, for which they are potentially eligible according to their current health conditions and to inform the corresponding physicians of their potential willingness to participate.

Find out more corner bottom
corner top

eISF

The electronic investigator site file

The eISF, or electronic Investigator Site File, is the digital version of the paper-based investigator site file (ISF). It enables the collection in digital form of essential documents that demonstrate a clinical trial was conducted in accordance with Good Clinical Practice (GCP) guidelines, as well as regulatory and sponsor requirements.

Find out more corner bottom

LATEST NEWSOUR NEWS >

telemedecine technologies news

14th Meeting of the CleanWeb™ Users Club

May 30, 2024

June 18, 2024 – 2:00 PM – 3:00 PM CEST Join us for the 14th meeting of the CleanWeb™ Users Group. This webinar is free and open to all our users. This afternoon traditionally serves as an opportunity to review the latest features developed for our users and to present upcoming developments. During this webinar, […]

READ MORE
telemedecine technologies news

Yes, Agile Can Work in Medtech

May 30, 2024

Med City News Three tips to succeed in a highly regulated environment. Medical devices take multiple years and millions of dollars to bring to market. Regulations play a huge role: medtech manufacturers must meet a range of requirements to get devices approved – or risk wasting their investment. The high cost of failure encourages many […]

READ MORE
telemedecine technologies news

Integrated Biosciences and Illumina Ventures Labs Collaborate on Novel Therapeutics Targeting the Transcriptome

May 30, 2024

BioPharm International The partnership will create therapeutic assets and new discovery platforms and potentially reshape drug discovery. Integrated Biosciences, a biotechnology company that uses synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases, announced on May 28, 2024, that it is collaborating with Illumina Ventures Labs to create novel therapeutics targeting the […]

READ MORE